核酸検査市場：適応症別、製品別、技術別、エンドユーザー別-2023～2030年の世界予測

核酸検査の世界市場は、2023年に34億3,893万米ドル、CAGR 10.28%で大きく成長し、2030年には68億3,230万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の核酸検査市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.核酸検査の世界市場規模および予測は？

2.予測期間中、世界の核酸検査市場を形成するCOVID-19の阻害要因と影響は？

3.核酸検査の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.核酸検査の世界市場における競争戦略は？

5.核酸検査の世界市場における技術動向と規制の枠組みは？

6.核酸検査の世界市場における主要ベンダーの市場シェアは？

7.核酸検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんやその他の感染症の増加
    • ヒト遺伝子検査の商業化の増加
    • パンデミックの制御と根絶における急激なニーズ
  • 抑制要因
    • 研究開発への巨額の支出
  • 機会
    • 検査能力を拡大するための魅力的な資金調達スペースと政府支援
    • 利用可能な政府の承認と償還の増加
  • 課題
    • 複雑な機器と技術
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 核酸検査市場：適応症別

• イントロダクション
• がん
• 法医学検査
• 遺伝的およびミトコンドリア障害
• 感染症

第7章 核酸検査市場：製品別

• イントロダクション
• 消耗品
• 核酸検査キット

第8章 核酸検査市場：技術別

• イントロダクション
• プローブ増幅システム
• 信号増幅
• ターゲット増幅システム

第9章 核酸検査市場：エンドユーザー別

• イントロダクション
• 病院
• 病理研究所
• 研究機関

第10章 南北アメリカの核酸検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の核酸検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの核酸検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. NUCLEIC ACID TESTING MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEIC ACID TESTING MARKET SIZE, 2022 VS 2030
• FIGURE 3. NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 6. NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2022 VS 2030 (%)
• FIGURE 7. NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. NUCLEIC ACID TESTING MARKET DYNAMICS
• FIGURE 10. NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. NUCLEIC ACID TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 10. NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 13. NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 189. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 190. NUCLEIC ACID TESTING MARKET LICENSE & PRICING

The Global Nucleic Acid Testing Market is forecasted to grow significantly, with a projected USD 3,438.93 million in 2023 at a CAGR of 10.28% and expected to reach a staggering USD 6,832.30 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Nucleic Acid Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Nucleic Acid Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Cancer, Forensic Testing, Genetic & Mitochondrial Disorders, and Infectious Disease. The Genetic & Mitochondrial Disorders is projected to witness significant market share during forecast period.

Based on Product, market is studied across Consumables and Nucleic Acid Test Kits. The Consumables is projected to witness significant market share during forecast period.

Based on Technique, market is studied across Probe Amplification Systems, Signal Amplification, and Target Amplification Systems. The Target Amplification Systems is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals, Pathology Laboratories, and Research Institutes. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Nucleic Acid Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Nucleic Acid Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nucleic Acid Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nucleic Acid Testing Market?

4. What is the competitive strategic window for opportunities in the Global Nucleic Acid Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Nucleic Acid Testing Market?

6. What is the market share of the leading vendors in the Global Nucleic Acid Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Nucleic Acid Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Nucleic Acid Testing Market, by Indication, 2022 vs 2030
• 4.3. Nucleic Acid Testing Market, by Product, 2022 vs 2030
• 4.4. Nucleic Acid Testing Market, by Technique, 2022 vs 2030
• 4.5. Nucleic Acid Testing Market, by End User, 2022 vs 2030
• 4.6. Nucleic Acid Testing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of cancer and other infectious diseases
    • 5.1.1.2. Increased commercialization of human genetic tests
    • 5.1.1.3. Exponential need in pandemic control and eradication
  • 5.1.2. Restraints
    • 5.1.2.1. Huge expenditure on R&D
  • 5.1.3. Opportunities
    • 5.1.3.1. Attractive funding space and government support to expand testing capabilities
    • 5.1.3.2. Increasing government approvals and reimbursements available
  • 5.1.4. Challenges
    • 5.1.4.1. Complex instrumentation and technology
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Nucleic Acid Testing Market, by Indication

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Forensic Testing
• 6.4. Genetic & Mitochondrial Disorders
• 6.5. Infectious Disease

7. Nucleic Acid Testing Market, by Product

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Nucleic Acid Test Kits

8. Nucleic Acid Testing Market, by Technique

• 8.1. Introduction
• 8.2. Probe Amplification Systems
• 8.3. Signal Amplification
• 8.4. Target Amplification Systems

9. Nucleic Acid Testing Market, by End User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Pathology Laboratories
• 9.4. Research Institutes

10. Americas Nucleic Acid Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Nucleic Acid Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Nucleic Acid Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing